| Code | CSB-MP5071MOV |
| Abbreviation | Recombinant Cynomolgus monkey LRRC15 protein, partial (Active) |
| MSDS | |
| Size | $138 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
LRRC15 is emerging as a stromal marker in cancer-associated fibroblasts and a potential target for tumor microenvironment-directed therapies, making well-characterized reagents essential for antibody development and ligand discovery. This mammalian-expressed protein spanning residues 22–538 captures the extracellular leucine-rich repeat domain architecture required for native receptor conformation and antibody epitope presentation. Functional ELISA validation demonstrates specific antibody binding with an EC50 of 4.100–5.074 ng/mL, directly supporting its use in therapeutic antibody epitope mapping, competitive inhibition screening, and blocking antibody validation assays. The protein meets quality thresholds commonly required for surface plasmon resonance and biolayer interferometry affinity characterization, with purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg, making it appropriate for drug discovery campaigns targeting stromal interactions in the tumor microenvironment.
There are currently no reviews for this product.